AIRLINK 69.40 Decreased By ▼ -3.66 (-5.01%)
BOP 4.90 Decreased By ▼ -0.19 (-3.73%)
CNERGY 4.24 Decreased By ▼ -0.13 (-2.97%)
DFML 31.66 Decreased By ▼ -0.79 (-2.43%)
DGKC 76.82 Increased By ▲ 1.33 (1.76%)
FCCL 19.97 Increased By ▲ 0.45 (2.31%)
FFBL 34.93 Decreased By ▼ -1.22 (-3.37%)
FFL 9.12 Decreased By ▼ -0.10 (-1.08%)
GGL 9.80 Decreased By ▼ -0.05 (-0.51%)
HBL 112.66 Decreased By ▼ -4.04 (-3.46%)
HUBC 132.80 Increased By ▲ 0.11 (0.08%)
HUMNL 6.95 Decreased By ▼ -0.15 (-2.11%)
KEL 4.19 Decreased By ▼ -0.22 (-4.99%)
KOSM 4.25 Decreased By ▼ -0.15 (-3.41%)
MLCF 36.45 Increased By ▲ 0.25 (0.69%)
OGDC 132.94 Decreased By ▼ -0.56 (-0.42%)
PAEL 22.50 Decreased By ▼ -0.10 (-0.44%)
PIAA 24.20 Decreased By ▼ -1.81 (-6.96%)
PIBTL 6.46 Decreased By ▼ -0.09 (-1.37%)
PPL 116.40 Increased By ▲ 1.09 (0.95%)
PRL 25.88 Decreased By ▼ -0.75 (-2.82%)
PTC 13.03 Decreased By ▼ -1.07 (-7.59%)
SEARL 51.95 Decreased By ▼ -1.50 (-2.81%)
SNGP 67.50 Increased By ▲ 0.25 (0.37%)
SSGC 10.54 Decreased By ▼ -0.16 (-1.5%)
TELE 8.23 Decreased By ▼ -0.19 (-2.26%)
TPLP 10.79 Increased By ▲ 0.04 (0.37%)
TRG 59.21 Decreased By ▼ -4.66 (-7.3%)
UNITY 25.14 Increased By ▲ 0.02 (0.08%)
WTL 1.27 No Change ▼ 0.00 (0%)
BR100 7,391 Decreased By -70.2 (-0.94%)
BR30 23,921 Decreased By -250.4 (-1.04%)
KSE100 70,683 Decreased By -419.1 (-0.59%)
KSE30 23,253 Decreased By -142 (-0.61%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published February 25, 2021

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed.